Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines
NCT05836012
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
329
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroenteritis
Interventions
BIOLOGICAL:
HIL-214
BIOLOGICAL:
Placebo
Sponsor
HilleVax